
Professor John Cleland
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Membership:
FESC Member
HFA Member
Follow
Biography
John Cleland is Emeritus Professor at the University of Glasgow in the United Kingdom.
His main interest is heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines. Particular current interests include myocardial substrate, congestion & inflammation, telemonitoring & theranostics.
He qualified from Glasgow in 1977, completed training at St. Mary's & Hammersmith Hospitals (London) and was subsequently awarded a British Heart Foundation Senior Fellowship in Glasgow. He was appointed Professor of Cardiology at University of Hull 1999-2013 and the National Heart & Lung Institute, Imperial College London 2013-18. He returned to Glasgow as Director of the Robertson Centre for Biostatistics & Clinical Trials 2016-2022 and subsequently (until 2026) as Professor of Cardiology.
He founded the European Journal of Heart Failure. He helped found and was Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure
Contributor content
Session
Debate: what is heart failure with preserved ejection fraction?
10 May 2026
Session
Congestion and volume status in heart failure
10 May 2026
Session
Heart failure and comorbidities: navigating complex interactions
9 May 2026
Session
Ask the Trialists - REBOOT-CNIC
30 August 2025
Session
Ask the Trialists - BETAMI-DANBLOCK
30 August 2025
Session
Guideline-directed medical therapy implementation in special clinical scenarios
17 May 2025
Session
Interventions for arrhythmia through the heart failure lens
1 September 2024
Session
Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?
12 May 2024
Session
Late-breaking science on risk in special populations
25 August 2023
Session
IV iron: the story so far
21 May 2023

